U.S. flag

An official website of the United States government

NM_001927.4(DES):c.347A>T (p.Asn116Ile) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 2, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000217696.4

Allele description [Variation Report for NM_001927.4(DES):c.347A>T (p.Asn116Ile)]

NM_001927.4(DES):c.347A>T (p.Asn116Ile)

Gene:
DES:desmin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_001927.4(DES):c.347A>T (p.Asn116Ile)
HGVS:
  • NC_000002.12:g.219418809A>T
  • NG_008043.1:g.5433A>T
  • NM_001927.4:c.347A>TMANE SELECT
  • NP_001918.3:p.Asn116Ile
  • LRG_380t1:c.347A>T
  • LRG_380:g.5433A>T
  • NC_000002.11:g.220283531A>T
  • NM_001927.3:c.347A>T
Protein change:
N116I
Links:
dbSNP: rs267607499
NCBI 1000 Genomes Browser:
rs267607499
Molecular consequence:
  • NM_001927.4:c.347A>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000271619Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Jul 2, 2015)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy.

Klauke B, Kossmann S, Gaertner A, Brand K, Stork I, Brodehl A, Dieding M, Walhorn V, Anselmetti D, Gerdes D, Bohms B, Schulz U, Zu Knyphausen E, Vorgerd M, Gummert J, Milting H.

Hum Mol Genet. 2010 Dec 1;19(23):4595-607. doi: 10.1093/hmg/ddq387. Epub 2010 Sep 9.

PubMed [citation]
PMID:
20829228

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000271619.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

The p.Asn116Ile variant in DES has not been previously reported in individuals w ith cardiomyopathy. Of note, a different amino acid alteration at this position (p.Asn116Ser) has been reported de novo in 1 individual with early-onset ARVC an d myofibrillar myopathy (Klauke 2010). Data from large population studies is ins ufficient to assess the frequency of this variant. Computational prediction tool s and conservation analysis suggest that the p.Asn116Ile variant may impact the protein, though this information is not predictive enough to determine pathogeni city. In summary, the clinical significance of the p.Asn116Ile variant is uncert ain.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Mar 5, 2024